Foundation Medicine logo

Foundation Medicine

North America, Massachusetts, United States, Cambridge

Description

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

Investor Profile

Foundation Medicine has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Grant rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Artificial Intelligence (AI), Biotechnology.

Stage Focus

  • Series B (50%)
  • Grant (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Artificial Intelligence (Ai)
  • Biotechnology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Foundation Medicine frequently co-invest with?

dRx Capital
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 1
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Regional Cancer Care Associates
North America, New Jersey, United States, Hackensack
Co-Investments: 1
Horizon Blue Cross Blue Shield of New Jersey
North America, New Jersey, United States, Newark
Co-Investments: 1
Med-Metrix
North America, New Jersey, United States, Parsippany
Co-Investments: 1

What are some of recent deals done by Foundation Medicine?

Moffitt Cancer Center

Tampa, Florida, United States

Moffitt Cancer Center are contribute to the prevention and cure of cancer.

Health Care
GrantJul 31, 2023
COTA Healthcare

New York, New York, United States

Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science
Series BMay 24, 2016